AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TELIX PHARMACEUTICALS LTD

9.850

-0.280-2.76%

Volume:3.00M

Turnover:29.31M

Market Cap:3.34B

PE:162.03

High:10.000

Open:10.000

Low:9.590

Close:10.130

52wk High:31.970

52wk Low:9.590

Shares:338.72M

Float Shares:275.41M

Volume Ratio:1.08

T/O Rate:1.09%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.061

EPS(LYR):0.206

ROE:3.14%

ROA:2.08%

PB:5.55

PE(LYR):47.78

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

BUZZ-Australia's Telix Pharma falls to over 2-year low as chair resigns

Telix Full Year Results 2025 Investor Webcast Notification

Assessing Telix Pharmaceuticals (ASX:TLX) Valuation After Regulatory Setbacks And Rising Investor Caution

Simply Wall St.

ASX Biggest Losers

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TLX.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TLX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TLX.AU\",,,,,undefined,":{"symbol":"TLX.AU","market":"AU","secType":"STK","nameCN":"TELIX PHARMACEUTICALS LTD","latestPrice":9.85,"timestamp":1770354720000,"preClose":10.13,"halted":0,"volume":3002322,"delay":0,"changeRate":-0.027640671273445324,"nameEN":"TELIX PHARMACEUTICALS LTD","floatShares":275410996,"shares":338721355,"eps":0.06079270031365839,"marketStatus":"Market Closed","change":-0.28,"latestTime":"02-06 16:12:00 AEDT","open":10,"high":10,"low":9.59,"amount":29312805,"amplitude":0.040474,"askPrice":9.88,"askSize":633,"bidPrice":9.8,"bidSize":300,"shortable":3,"etf":0,"ttmEps":0.06079270031365839,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770591600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":10.13,"openAndCloseTimeList":[[1770332400000,1770354000000]],"volumeRatio":1.0760365130780325,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TLX.AU\",,,,,undefined,":{"symbol":"TLX.AU","floatShares":275410996,"roa":"2.08%","roe":"3.14%","lyrEps":0.206159,"volumeRatio":1.0760365130780325,"shares":338721355,"dividePrice":0,"high":10,"amplitude":0.040474,"preClose":10.13,"low":9.59,"week52Low":9.59,"pbRate":"5.55","psRate":"3.52","week52High":31.97,"institutionHeld":0,"latestPrice":9.85,"committee":-0.356913,"eps":0.06079270031365839,"divideRate":0,"volume":3002322,"delay":0,"ttmEps":0.06079270031365839,"open":10,"prevYearClose":11.2,"prevWeekClose":10.55,"prevMonthClose":10.55,"prevQuarterClose":11.2,"fiveDayClose":10.55,"twentyDayClose":11.33,"sixtyDayClose":15.32,"earningDate":1771430400000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TLX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-02-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771455600000,"name":null,"time":"","dateTimestamp":1771419600000,"actualEps":null},{"date":"2026-01-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1768777200000,"name":null,"time":"","dateTimestamp":1768741200000,"actualEps":null},{"date":"2025-08-21","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755734400000,"name":null,"time":"","dateTimestamp":1755698400000,"actualEps":null},{"date":"2025-02-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739919600000,"name":null,"time":"","dateTimestamp":1739883600000,"actualEps":null},{"date":"2024-08-22","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724284800000,"name":null,"time":"","dateTimestamp":1724248800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TLX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TLX.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609530079","title":"BUZZ-Australia's Telix Pharma falls to over 2-year low as chair resigns","url":"https://stock-news.laohu8.com/highlight/detail?id=2609530079","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609530079?lang=en_us&edition=fundamental","pubTime":"2026-02-06 11:53","pubTimestamp":1770350004,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Telix Pharma falls to over 2-year low as chair resigns** Shares of Australia's Telix Pharmaceuticals TLX.AX down 7.3% so far this week, set for their steepest weekly drop since the we","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nL6N3Z208X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","TLX.AU"],"gpt_icon":0},{"id":"2608383457","title":"Telix Full Year Results 2025 Investor Webcast Notification","url":"https://stock-news.laohu8.com/highlight/detail?id=2608383457","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608383457?lang=en_us&edition=fundamental","pubTime":"2026-02-04 05:38","pubTimestamp":1770154680,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia and INDIANAPOLIS, Feb. 4, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited  advises that it will release its full year results for the period ended 31 December 2025 on Friday 20 February 2026 AEDT .An investor webcast and conference call will be held at 9:30 a.m. AEDT, Friday 20 February 2026 .Annie Kasparian Telix Pharmaceuticals Limited Director Investor Relations and Corporate Communications Email: [emailprotected]. The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to securities of Telix Pharmaceuticals Limited  in any jurisdiction, including the United States. The information and opinions contained in this announcement are subject to change without notification. To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to update or revise any information or opinions contained in this announcement, including any forward-looking statements , wheth","market":"nz","thumbnail":"https://mma.prnewswire.com/media/1920208/Telix_Main_Logo_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/1920208/Telix_Main_Logo_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/telix-full-year-results-2025-investor-webcast-notification-302678211.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7039","TLX.AU","ASX.AU","BK4141","BK7067","TLX","SEC.AU","BK4526","BK4139","ASX","BK4543"],"gpt_icon":0},{"id":"2608825088","title":"Assessing Telix Pharmaceuticals (ASX:TLX) Valuation After Regulatory Setbacks And Rising Investor Caution","url":"https://stock-news.laohu8.com/highlight/detail?id=2608825088","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608825088?lang=en_us&edition=fundamental","pubTime":"2026-02-03 12:51","pubTimestamp":1770094266,"startTime":"0","endTime":"0","summary":"Regulatory setbacks put Telix Pharmaceuticals (ASX:TLX) under closer investor scrutiny\nTelix Pharmaceuticals (ASX:TLX) is back in focus after three FDA rejections and an ongoing SEC investigation. These events have coincided with a sharp share price pullback and heightened regulatory risk.\nSee our latest analysis for Telix Pharmaceuticals.\nThe regulatory setbacks have coincided with a steep reset in sentiment, with a 90 day share price return of a 33.46% decline and a 1 year total shareholder...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/assessing-telix-pharmaceuticals-asxtlx-valuation-after-regul","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/assessing-telix-pharmaceuticals-asxtlx-valuation-after-regul","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TLX","BK4139","BK7067","TLX.AU"],"gpt_icon":0},{"id":"2608438628","title":"ASX Biggest Losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2608438628","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608438628?lang=en_us&edition=fundamental","pubTime":"2026-02-03 11:20","pubTimestamp":1770088812,"startTime":"0","endTime":"0","summary":"Here are the 10 ASX-listed companies with the biggest losses on Tuesday.Contact Energy : -5%, AU$8.06Ventia Services Group : -4%, AU$5.55Telix Pharmaceuticals : -3%, AU$10.14Ebos Group : -2%, AU$21.9Mineral Resources : -2%, AU$55.24Meridian Energy : -2%, AU$4.83ARB : -2%, AU$25.81Abacus Storage King : -2%, AU$1.53Virgin Australia Holdings : -2%, AU$3.1Summerset Group Holdings  : -1%, AU$10","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7507","BK7006","BK7113","SNZ.AU","BK7060","BK7030","BK7067","MEZ.AU","BK7504","EBO.AU","TLX.AU","BK7103","BK7095","VGN.AU","BK7055","CEN.AU","VNT.AU","MIN.AU","ARB.AU","BK7151","BK7051","ASK.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":37,"pageCount":1,"totalSize":146,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/TLX.AU\",params:#limit:6,delay:true,,,undefined,":[]}}